Stock Market Today With IBD Mixed But Positive Market Action; Eli Lilly, Deutsche Bank, Nebius In Focus
Nov 11, 2025
Ken and Ed analyze the mixed market action, highlighting the Dow's gains driven by healthcare stocks. They discuss intriguing stocks like Eli Lilly, noting its impressive breakout and dominance in obesity treatments. Deutsche Bank's recent technical breakout catches their attention, while they ponder the implications of Nebius's fluctuating stock performance post-Microsoft deal. The duo also examines the outperformance of gold and miners, along with a shift toward blue-chip stocks in the current market landscape.
AI Snips
Chapters
Transcript
Episode notes
Dow Strength Masks Broader Market Calm
- The Dow led gains driven by healthcare while the broader market stayed mixed and mostly flat.
- This divergence suggests money rotated into defensive blue chips rather than speculative tech bets.
Confirm Strength By Holding Post-Reversal Gains
- Treat recent market action as constructive if indexes hold gains after reversals and bounces.
- Use such hold-backs as confirmation before increasing exposure to risky names.
ETF Weakness Doesn’t Equal Broad Tech Breakdown
- Growth and AI-focused ETFs like FFTY and ARKK underperformed after big prior gains.
- Individual names' chart positions (e.g., NVIDIA) change how declines impact technical outlooks.